AJP - Renal Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Renal Physiol 293: F801-F812, 2007. First published July 3, 2007; doi:10.1152/ajprenal.00044.2007
0363-6127/07 $8.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
293/3/F801    most recent
00044.2007v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (1)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mohib, K.
Right arrow Articles by Jevnikar, A. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mohib, K.
Right arrow Articles by Jevnikar, A. M.

Proapoptotic activity of indoleamine 2,3-dioxygenase expressed in renal tubular epithelial cells

Kanishka Mohib,1,2 Qiunong Guan,2 Hong Diao,2 Caigan Du,1,2,3,4 and Anthony M. Jevnikar1,2,3,4

1Departments of Medicine and Microbiology and Immunology, The University of Western Ontario, London, Ontario; 2The Robarts Research Institute, London, Ontario; 3The Lawson Health Research Institute, London, Ontario; and 4The Multi-Organ Transplant Program, London Health Sciences Center, London, Ontario, Canada

Submitted 27 January 2007 ; accepted in final form 28 June 2007

Exposure of renal tubular epithelial cells (TEC) to IFN-{gamma}/TNF-{alpha} leads to Fas/FasL-mediated self-injury, which contributes to allograft rejection. Indoleamine 2,3-dioxygenase (IDO) converts tryptophan to N-formyl-kynurenine and contributes to immune privilege in tissues by increasing Fas-mediated T cell apoptosis. However, renal expression of IDO and its role in promoting Fas-mediated TEC death have not been examined. IDO expression was analyzed by RT-PCR and Western blot. Apoptosis was measured by fluorescence-activated cell sorting analysis and terminal deoxytransferase-mediated dUTP nick end labeling. We demonstrated that functional IDO is expressed in TEC and is increased by IFN-{gamma}/TNF-{alpha} exposure. Increased IDO activity promoted TEC apoptosis, whereas inhibition of IDO by its specific inhibitor 1-methyl-D-tryptophan attenuated IFN-{gamma}/TNF-{alpha}-mediated TEC apoptosis and augmented TEC survival. Transgenic expression of IDO resulted in increased TEC apoptosis in the absence of proinflammatory cytokine exposure, supporting a central role for IDO in TEC injury. Inhibition of IDO-mediated TEC death by a caspase-8-specific inhibitor (Z-IETD-FMK), as well as the absence of an IDO effect in Fas-deficient and FasL-deficient TEC, supports a Fas/FasL-dependent, caspase-8-mediated mechanism for IDO-enhanced TEC death. These data suggest that renal IDO expression may be deleterious during renal inflammation, because it enhances TEC self-injury through Fas/FasL interactions. Thus attenuation of IDO may represent a novel strategy to promote kidney function following ischemia and renal allograft rejection.

tubular epithelium; apoptosis



Address for reprint requests and other correspondence: A. M. Jevnikar, Division of Nephrology, Dept. of Medicine, Univ. of Western Ontario, Univ. Campus, 339 Windermere Road, London, ON, Canada N6A 5A5 (e-mail: jevnikar{at}uwo.ca)




This article has been cited by other articles:


Home page
Am. J. Physiol. Renal Physiol.Home page
K. Mohib, S. Wang, Q. Guan, A. L. Mellor, H. Sun, C. Du, and A. M. Jevnikar
Indoleamine 2,3-dioxygenase expression promotes renal ischemia-reperfusion injury
Am J Physiol Renal Physiol, July 1, 2008; 295(1): F226 - F234.
[Abstract] [Full Text] [PDF]


Home page
CJASNHome page
A. M. Jevnikar and R. B. Mannon
Late Kidney Allograft Loss: What We Know about It, and What We Can Do about It
Clin. J. Am. Soc. Nephrol., March 1, 2008; 3(Supplement_2): S56 - S67.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2007 by the American Physiological Society.